Geron Corp. (GERN) Dividend History
Geron Corp is a biopharmaceutical company. It supports the clinical stage development of a telomerase inhibitor, imetelstat.
Last update 12/11/2023
Dividend Yield Summary
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
| Dividends | - | - | - | - | - | - |
| Average Price | 1.45 | 1.60 | 1.50 | 1.76 | 2.64 | - |
| Yield | - | - | - | - | - | - |
Dividend History
No history of dividends
| Date | Amount Per Share | Note |